Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportClinical Neurosciences (including neuro-oncology)

123I-iomazenil SPECT can detect specific impairment of neuronal integrity in traumatic brain injury with diffuse axonal injury.

Hiroki Kato, Jyoji Nakagawara, Kenji Hachisuka, Jun Hatazawa, Katsunori Ikoma, Eiichi Suehiro, Hidehiko Iida, Kuniaki Ogasawara, Osamu Iizuka, Sumio Ishiai, Tadashi Ichikawa, Tadashi Nariai, Tetsuya Okazaki, Tohru Shiga and Etsuro Mori
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2947;
Hiroki Kato
1Nakamura Memorial Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jyoji Nakagawara
1Nakamura Memorial Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenji Hachisuka
2University of Occupational and Environmental Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Hatazawa
3Osaka University Graduate School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katsunori Ikoma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eiichi Suehiro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hidehiko Iida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kuniaki Ogasawara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osamu Iizuka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sumio Ishiai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tadashi Ichikawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tadashi Nariai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tetsuya Okazaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tohru Shiga
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Etsuro Mori
4Osaka University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

2947

Introduction: Objective assessment of the neuronal abnormalities in cases of traumatic brain injury (TBI) with diffuse axonal injury (DAI) is crucial to understanding the underlying pathology, as well as from the point of view of facilitating socioeconomic support for these patients. Neuronal integrity can be evaluated by benzodiazepine binding using 123I-iomazenil (IMZ) SPECT. The purpose of this study was to investigate the extent of neuronal damage in cases of TBI with DAI using 123I-IMZ SPECT and MRI.

Methods: We compared the findings in 31 patients with TBI without any major focal brain lesions and 25 age-matched normal controls. Subjects underwent 123I-IMZ SPECT and MRI, and also assessment by cognitive function tests. The partial volume effect of 123I-IMZ SPECT was corrected using MRI. Regional benzodiazepine binding and brain atrophy in TBI were assessed based on the volume of interest and voxel-based analysis.

Results: In the patients with TBI, decreased binding of IMZ was detected in the medial frontal/orbitofrontal cortex, posterior cingulate gyrus, cuneus, precuneus, and superior region of the cerebellum. The decreased IMZ binding in the cuneus and precuneus was associated with cognitive decline after the injury. In the patients with TBI, brain atrophy was detected in the frontal lobe, anterior temporal and parietal cortex, corpus callosum, and posterior part of the cerebellum. ROC analysis of 123I-IMZ SPECT for the detection of neuronal injury showed a high diagnostic ability of IMZ binding for TBI in the cingulate gyrus, medial regions of the frontal, parietal, and occipital lobes, and superior region of the cerebellum.

Conclusions: In patients with TBI in whom the major pathology was DAI, decreased binding of IMZ, that is, decreased neuronal integrity, was detected in the medial frontal or orbitofrontal cortex, posterior cingulate gyrus, cuneus, precuneus, and superior region of the cerebellum. Decrease in IMZ binding in the cuneus and precuneus was associated with cognitive decline after the injury. On the other hand, brain atrophy in the patients with TBI was detected in the frontal lobe, anterior temporal and parietal cortex, corpus callosum, and posterior part of the cerebellum. 123I-IMZ SPECT with PVC provides reliable diagnostic information and relevant insights into the pathology and mechanism of injury in cases of TBI.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
123I-iomazenil SPECT can detect specific impairment of neuronal integrity in traumatic brain injury with diffuse axonal injury.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
123I-iomazenil SPECT can detect specific impairment of neuronal integrity in traumatic brain injury with diffuse axonal injury.
Hiroki Kato, Jyoji Nakagawara, Kenji Hachisuka, Jun Hatazawa, Katsunori Ikoma, Eiichi Suehiro, Hidehiko Iida, Kuniaki Ogasawara, Osamu Iizuka, Sumio Ishiai, Tadashi Ichikawa, Tadashi Nariai, Tetsuya Okazaki, Tohru Shiga, Etsuro Mori
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2947;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
123I-iomazenil SPECT can detect specific impairment of neuronal integrity in traumatic brain injury with diffuse axonal injury.
Hiroki Kato, Jyoji Nakagawara, Kenji Hachisuka, Jun Hatazawa, Katsunori Ikoma, Eiichi Suehiro, Hidehiko Iida, Kuniaki Ogasawara, Osamu Iizuka, Sumio Ishiai, Tadashi Ichikawa, Tadashi Nariai, Tetsuya Okazaki, Tohru Shiga, Etsuro Mori
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2947;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Comparison of Visual and Voxel-Wise Brain SPECT/CT Analysis in Patients With Long Term Schizophrenia Following Aripiprazole Monotherapy: A Clinical Trial
  • Autoimmune encephalitis: Is FDG PET the key to diagnosis?
  • Multiparametric imaging with integrated 11C-methionine (MET) PET/MR for differentiation between tumor progression and treatment related changes for glioma patients
Show more Clinical Neurosciences (including neuro-oncology)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire